Skip to content

About Us
- Management Team
Pipeline
Past Partner Deals
Past and Current
Partners & Affiliates
News
Contact Us

Menu

Home » News » Camelot BioCapital Licenses Liu Cancer Therapy

Camelot BioCapital Licenses Liu Cancer Therapy

Post navigation

iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors

Vera

View posts by Vera

Search

Recent Posts

Recent Comments

No comments to show.

NYC
Palm Beach
Tel Aviv
Perth
Basel
Gainesville
Houston

Home
About Us
Pipeline
Past Partner Deals
Past and Current Partners & Affiliates
News
Contact Us
Sitemap

Investments in private placements involve a high degree of risk and may result in a partial or total loss of your investment. Private placements are generally illiquid investments. Investors should consult with their investment, legal, and tax advisors regarding any private placement investment.

All members of Camelot Investment Services, LLC are registered representatives and Securities offered through Stonehaven, LLC – Member FINRA/SIPC . Regulatory disclosures: Disclaimers & Risks, Privacy Policy and Form CRS.

© Camelot BioCapital. All rights reserved

Website by Axxiem

Scroll to top